Singapore markets close in 5 hours 30 minutes

Acurx Pharmaceuticals Inc (3ZO.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.0450-0.0100 (-0.49%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,038
6,044
4,754
2,030
2,203
Selling general and administrative
7,422
8,534
7,339
10,784
2,397
Total operating expenses
11,459
14,578
12,093
12,814
4,600
Operating income or loss
-11,459
-14,578
-12,093
-12,814
-4,600
Total other income/expenses net
-
-
-
66.503
-
Income before tax
-11,459
-14,578
-12,093
-12,748
-4,600
Income from continuing operations
-11,459
-14,578
-12,093
-12,748
-4,600
Net income
-11,459
-14,578
-12,093
-12,748
-4,600
Net income available to common shareholders
-11,459
-14,578
-12,093
-12,748
-4,600
Basic EPS
-1.05
-1.15
-1.12
-1.49
-0.48
Diluted EPS
-1.05
-1.15
-1.12
-1.49
-0.48
Basic average shares
12,114
12,672
10,816
8,536
9,541
Diluted average shares
12,114
12,672
10,816
8,536
9,541